VectorY Therapeutics

Barbara Sanders, Ph.D., Vice President, Vector Development

Oct. 13 | 11:45am | Oxford Biomedica Ballroom 

Amsterdam, Netherlands  


In-person Presentation 

VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. Founded in August 2020, and based in the Amsterdam Science Park, VectorY is a fully integrated gene therapy company focused on the development of innovative therapeutics such as vectorized antibodies for both CNS and somatic disorders, with a special focus on muscle diseases.

By using this website you agree to accept our Privacy Policy and Terms & Conditions